Singapore markets closed
Straits Times Index
3,426.47 -3.98 (-0.12%) Nikkei
37,667.41 -202.10 (-0.53%) Hang Seng
17,021.31 +16.34 (+0.10%) FTSE 100
8,285.71 +99.36 (+1.21%) Bitcoin USD
67,968.66 +878.05 (+1.31%) CMC Crypto 200
1,375.17 +44.56 (+3.35%)
Abrdn Life Sciences Investors (HQL)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 421.74M |
| Enterprise value | N/A |
| Trailing P/E | 11.51 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 11.11 |
| Price/book (mrq) | 0.96 |
| Enterprise value/revenue | 10.56 |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 0.71 |
| 52-week change 3 | 14.65% |
| S&P500 52-week change 3 | 18.96% |
| 52-week high 3 | 15.63 |
| 52-week low 3 | 11.34 |
| 50-day moving average 3 | 14.21 |
| 200-day moving average 3 | 13.40 |
Share statistics
| Avg vol (3-month) 3 | 95.89k |
| Avg vol (10-day) 3 | 219.43k |
| Shares outstanding 5 | 27.35M |
| Implied shares outstanding 6 | 27.35M |
| Float 8 | N/A |
| % held by insiders 1 | 0.01% |
| % held by institutions 1 | 35.69% |
| Shares short (15 Jul 2024) 4 | 5.17k |
| Short ratio (15 Jul 2024) 4 | 0.24 |
| Short % of float (15 Jul 2024) 4 | N/A |
| Short % of shares outstanding (15 Jul 2024) 4 | 0.02% |
| Shares short (prior month 14 Jun 2024) 4 | 9.55k |
Dividends & splits
| Forward annual dividend rate 4 | 1.49 |
| Forward annual dividend yield 4 | 9.66% |
| Trailing annual dividend rate 3 | 1.30 |
| Trailing annual dividend yield 3 | 8.45% |
| 5-year average dividend yield 4 | 9.18 |
| Payout ratio 4 | 99.25% |
| Dividend date 3 | 31 Dec 2018 |
| Ex-dividend date 4 | 22 May 2024 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Sept 2022 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 156.45% |
| Operating margin (ttm) | -31.63% |
Management effectiveness
| Return on assets (ttm) | -0.32% |
| Return on equity (ttm) | 1.28% |
Income statement
| Revenue (ttm) | 3.51M |
| Revenue per share (ttm) | 0.13 |
| Quarterly revenue growth (yoy) | 7.00% |
| Gross profit (ttm) | N/A |
| EBITDA | N/A |
| Net income avi to common (ttm) | 5.5M |
| Diluted EPS (ttm) | 1.34 |
| Quarterly earnings growth (yoy) | 48.70% |
Balance sheet
| Total cash (mrq) | N/A |
| Total cash per share (mrq) | N/A |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.27 |
| Book value per share (mrq) | 16.13 |
Cash flow statement
| Operating cash flow (ttm) | N/A |
| Levered free cash flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.